| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-09 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |